Zach Richardson

Stable nebulization and muco‐trapping properties of regdanvimab/IN‐006 support its development as a potent, dose‐saving inhaled therapy for COVID‐19

Priya A. Kumar, A. Hickey, Soo Young Lee, 2022, bioRxiv.